Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
25
SHPH Quote, Financials, Valuation and Earnings
Last price:
$1.96
Seasonality move
:
-36.33%
Day range:
$1.85 - $2.08
52-week range:
$1.26 - $25.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
16.07x
Volume:
174.5K
Avg. volume:
318.6K
1-year change:
-91.25%
Market cap:
$22.4M
Revenue:
--
EPS (TTM):
-$14.45
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
JNJ
Johnson & Johnson
|
$24.1B | $2.52 | 5.28% | -39.57% | $210.13 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.37 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
|
$2.04 | -- | $22.4M | -- | $0.00 | 0% | -- |
|
JNJ
Johnson & Johnson
|
$204.31 | $210.13 | $492.2B | 19.72x | $1.30 | 2.52% | 5.38x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$6.75 | $0.85 | $850.6M | 11.34x | $0.80 | 0% | 13.11x |
|
OGEN
Oragenics, Inc.
|
$0.87 | $2.00 | $719.1K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.24 | $7.00 | $8.1M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
|
32.37% | 1.414 | 1.71% | 1.07x |
|
JNJ
Johnson & Johnson
|
36.62% | -0.032 | 10.26% | 0.71x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | -3.190 | 8.08% | 1.85x |
|
OGEN
Oragenics, Inc.
|
3.86% | 0.905 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -2.522 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
|
-$1K | -$2.3M | -449.76% | -697.07% | -- | -$2.6M |
|
JNJ
Johnson & Johnson
|
$16.7B | $7.1B | 20.94% | 33.27% | 29.64% | $8B |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
Shuttle Pharmaceuticals Holdings, Inc. vs. Competitors
-
Which has Higher Returns SHPH or JNJ?
Johnson & Johnson has a net margin of -- compared to Shuttle Pharmaceuticals Holdings, Inc.'s net margin of 21.47%. Shuttle Pharmaceuticals Holdings, Inc.'s return on equity of -697.07% beat Johnson & Johnson's return on equity of 33.27%.
Company Gross Margin Earnings Per Share Invested Capital SHPHShuttle Pharmaceuticals Holdings, Inc.-- -$1.05 $2.1M JNJJohnson & Johnson69.72% $2.12 $125.1B -
What do Analysts Say About SHPH or JNJ?
Shuttle Pharmaceuticals Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Johnson & Johnson has an analysts' consensus of $210.13 which suggests that it could grow by 2.85%. Given that Johnson & Johnson has higher upside potential than Shuttle Pharmaceuticals Holdings, Inc., analysts believe Johnson & Johnson is more attractive than Shuttle Pharmaceuticals Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHPHShuttle Pharmaceuticals Holdings, Inc.0 0 0 JNJJohnson & Johnson9 11 0 -
Is SHPH or JNJ More Risky?
Shuttle Pharmaceuticals Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Johnson & Johnson has a beta of 0.341, suggesting its less volatile than the S&P 500 by 65.861%.
-
Which is a Better Dividend Stock SHPH or JNJ?
Shuttle Pharmaceuticals Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Johnson & Johnson offers a yield of 2.52% to investors and pays a quarterly dividend of $1.30 per share. Shuttle Pharmaceuticals Holdings, Inc. pays -- of its earnings as a dividend. Johnson & Johnson pays out 84.8% of its earnings as a dividend. Johnson & Johnson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHPH or JNJ?
Shuttle Pharmaceuticals Holdings, Inc. quarterly revenues are --, which are smaller than Johnson & Johnson quarterly revenues of $24B. Shuttle Pharmaceuticals Holdings, Inc.'s net income of -$2.3M is lower than Johnson & Johnson's net income of $5.2B. Notably, Shuttle Pharmaceuticals Holdings, Inc.'s price-to-earnings ratio is -- while Johnson & Johnson's PE ratio is 19.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shuttle Pharmaceuticals Holdings, Inc. is -- versus 5.38x for Johnson & Johnson. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHPHShuttle Pharmaceuticals Holdings, Inc.-- -- -- -$2.3M JNJJohnson & Johnson5.38x 19.72x $24B $5.2B
-
Which has Higher Returns SHPH or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -- compared to Shuttle Pharmaceuticals Holdings, Inc.'s net margin of -255.85%. Shuttle Pharmaceuticals Holdings, Inc.'s return on equity of -697.07% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital SHPHShuttle Pharmaceuticals Holdings, Inc.-- -$1.05 $2.1M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About SHPH or NBY?
Shuttle Pharmaceuticals Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -87.41%. Given that NovaBay Pharmaceuticals, Inc. has higher upside potential than Shuttle Pharmaceuticals Holdings, Inc., analysts believe NovaBay Pharmaceuticals, Inc. is more attractive than Shuttle Pharmaceuticals Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHPHShuttle Pharmaceuticals Holdings, Inc.0 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is SHPH or NBY More Risky?
Shuttle Pharmaceuticals Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.093, suggesting its less volatile than the S&P 500 by 90.725%.
-
Which is a Better Dividend Stock SHPH or NBY?
Shuttle Pharmaceuticals Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. Shuttle Pharmaceuticals Holdings, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHPH or NBY?
Shuttle Pharmaceuticals Holdings, Inc. quarterly revenues are --, which are smaller than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. Shuttle Pharmaceuticals Holdings, Inc.'s net income of -$2.3M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, Shuttle Pharmaceuticals Holdings, Inc.'s price-to-earnings ratio is -- while NovaBay Pharmaceuticals, Inc.'s PE ratio is 11.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shuttle Pharmaceuticals Holdings, Inc. is -- versus 13.11x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHPHShuttle Pharmaceuticals Holdings, Inc.-- -- -- -$2.3M NBYNovaBay Pharmaceuticals, Inc.13.11x 11.34x $521K -$1.3M
-
Which has Higher Returns SHPH or OGEN?
Oragenics, Inc. has a net margin of -- compared to Shuttle Pharmaceuticals Holdings, Inc.'s net margin of --. Shuttle Pharmaceuticals Holdings, Inc.'s return on equity of -697.07% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital SHPHShuttle Pharmaceuticals Holdings, Inc.-- -$1.05 $2.1M OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About SHPH or OGEN?
Shuttle Pharmaceuticals Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 128.86%. Given that Oragenics, Inc. has higher upside potential than Shuttle Pharmaceuticals Holdings, Inc., analysts believe Oragenics, Inc. is more attractive than Shuttle Pharmaceuticals Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHPHShuttle Pharmaceuticals Holdings, Inc.0 0 0 OGENOragenics, Inc.1 0 0 -
Is SHPH or OGEN More Risky?
Shuttle Pharmaceuticals Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.903, suggesting its less volatile than the S&P 500 by 9.685%.
-
Which is a Better Dividend Stock SHPH or OGEN?
Shuttle Pharmaceuticals Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shuttle Pharmaceuticals Holdings, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHPH or OGEN?
Shuttle Pharmaceuticals Holdings, Inc. quarterly revenues are --, which are smaller than Oragenics, Inc. quarterly revenues of --. Shuttle Pharmaceuticals Holdings, Inc.'s net income of -$2.3M is higher than Oragenics, Inc.'s net income of -$3.1M. Notably, Shuttle Pharmaceuticals Holdings, Inc.'s price-to-earnings ratio is -- while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shuttle Pharmaceuticals Holdings, Inc. is -- versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHPHShuttle Pharmaceuticals Holdings, Inc.-- -- -- -$2.3M OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns SHPH or PTN?
Palatin Technologies has a net margin of -- compared to Shuttle Pharmaceuticals Holdings, Inc.'s net margin of --. Shuttle Pharmaceuticals Holdings, Inc.'s return on equity of -697.07% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SHPHShuttle Pharmaceuticals Holdings, Inc.-- -$1.05 $2.1M PTNPalatin Technologies-- -- -- -
What do Analysts Say About SHPH or PTN?
Shuttle Pharmaceuticals Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than Shuttle Pharmaceuticals Holdings, Inc., analysts believe Palatin Technologies is more attractive than Shuttle Pharmaceuticals Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHPHShuttle Pharmaceuticals Holdings, Inc.0 0 0 PTNPalatin Technologies0 0 0 -
Is SHPH or PTN More Risky?
Shuttle Pharmaceuticals Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock SHPH or PTN?
Shuttle Pharmaceuticals Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shuttle Pharmaceuticals Holdings, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHPH or PTN?
Shuttle Pharmaceuticals Holdings, Inc. quarterly revenues are --, which are larger than Palatin Technologies quarterly revenues of --. Shuttle Pharmaceuticals Holdings, Inc.'s net income of -$2.3M is higher than Palatin Technologies's net income of --. Notably, Shuttle Pharmaceuticals Holdings, Inc.'s price-to-earnings ratio is -- while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shuttle Pharmaceuticals Holdings, Inc. is -- versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHPHShuttle Pharmaceuticals Holdings, Inc.-- -- -- -$2.3M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns SHPH or TOVX?
Theriva Biologics, Inc. has a net margin of -- compared to Shuttle Pharmaceuticals Holdings, Inc.'s net margin of --. Shuttle Pharmaceuticals Holdings, Inc.'s return on equity of -697.07% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital SHPHShuttle Pharmaceuticals Holdings, Inc.-- -$1.05 $2.1M TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About SHPH or TOVX?
Shuttle Pharmaceuticals Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 2804.56%. Given that Theriva Biologics, Inc. has higher upside potential than Shuttle Pharmaceuticals Holdings, Inc., analysts believe Theriva Biologics, Inc. is more attractive than Shuttle Pharmaceuticals Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHPHShuttle Pharmaceuticals Holdings, Inc.0 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is SHPH or TOVX More Risky?
Shuttle Pharmaceuticals Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.343, suggesting its less volatile than the S&P 500 by 65.729%.
-
Which is a Better Dividend Stock SHPH or TOVX?
Shuttle Pharmaceuticals Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shuttle Pharmaceuticals Holdings, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHPH or TOVX?
Shuttle Pharmaceuticals Holdings, Inc. quarterly revenues are --, which are smaller than Theriva Biologics, Inc. quarterly revenues of --. Shuttle Pharmaceuticals Holdings, Inc.'s net income of -$2.3M is higher than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, Shuttle Pharmaceuticals Holdings, Inc.'s price-to-earnings ratio is -- while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shuttle Pharmaceuticals Holdings, Inc. is -- versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHPHShuttle Pharmaceuticals Holdings, Inc.-- -- -- -$2.3M TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 36x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
RGC alert for Jan 6
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Buy
73
INOD alert for Jan 6
Innodata, Inc. [INOD] is up 4.84% over the past day.
Buy
65
AVAV alert for Jan 6
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.
